SBC Medical Group Holdings (SBC) Non-Current Deffered Revenue (2022 - 2024)

SBC Medical Group Holdings has reported Non-Current Deffered Revenue for 3 years, with the latest figure at $4.0 million in Q2 2024.

• For the quarter ending Q2 2024, Non-Current Deffered Revenue changed 0.0% year-over-year to $4.0 million; the trailing twelve-month figure through Jun 2024 stood at $4.0 million (changed 0.0% YoY), and the FY2023 full-year result was $4.0 million, changed 0.0% from the prior year.
• Non-Current Deffered Revenue for Q2 2024 stood at $4.0 million, roughly flat from $4.0 million in the prior quarter.
• The five-year high for Non-Current Deffered Revenue was $4.0 million in Q4 2022, with the low at $4.0 million in Q4 2022.
• Historically, Non-Current Deffered Revenue has averaged $4.0 million across 3 years, with a median of $4.0 million in 2022.
• The largest YoY upside for Non-Current Deffered Revenue was 0.0% in 2023 against a maximum downside of 0.0% in 2023.
• SBC Medical Group Holdings' Non-Current Deffered Revenue stood at $4.0 million in 2022, then changed by 0.0% to $4.0 million in 2023, then changed by 0.0% to $4.0 million in 2024.
• The last three Non-Current Deffered Revenue figures came in at $4.0 million (Q2 2024), $4.0 million (Q1 2024), and $4.0 million (Q4 2023), per Business Quant data.